Aberrant <i>EVI1</i> splicing contributes to <i>EVI1</i>-rearranged leukemia
Atsushi Tanaka(Kyoto University), Daichi Inoue(Tokyo University of Science), Muran Xiao(Foundation for Biomedical Research and Innovation), Marije Havermans(Oncode Institute), Toshiya Inaba(Hiroshima University), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Yumi Aoyama(Kyoto University), Hideaki Nakajima(National Institute of Advanced Industrial Science and Technology), Yasutaka Hayashi(Tokyo Medical and Dental University), Simon J. Hogg(Memorial Sloan Kettering Cancer Center), Hiroyoshi Kunimoto(Yokohama City University), Weijia Zang(Kyoto University), Akihiko Yokoyama(Chiba Cancer Center), Ruud Delwel(Erasmus MC Cancer Institute), Taizo A. Nakano(Children's Hospital Colorado), Stanley Chun-Wei Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Miho Koizumi(Tokyo Women's Medical University), Akinori Kanai(Frontier Medical College), Masaki Nomura, Roger Mulet‐Lazaro(Oncode Institute), Miki Fukumoto(Hyogo Medical University), Jan Philipp Bewersdorf(Memorial Sloan Kettering Cancer Center), Yifan Zhang(Guangzhou University of Chinese Medicine), Bo Liu(Peking University), Hana Cho(Memorial Sloan Kettering Cancer Center), Hiroaki Honda(Tokyo Women's Medical University), Yui Koike(Foundation for Biomedical Research and Innovation), Hiromi Yamazaki(Hirosaki University), Hiroshi Kawamoto(Fujita Health University), Alex Penson(Memorial Sloan Kettering Cancer Center), Tsuyoshi Konuma(Yokohama City University)
Cited by 24
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k